Antitope to Present at "2nd Annual Conference on Recombinant Antibodies" Berlin, Feb 27 2008
Antitope to Present at "2nd Annual Conference on Recombinant Antibodies" Melia Hotel, Berlin, Feb 27th 2008
Dr Matthew Baker, Chief Scientific Officer, will be presenting a paper entitled "Assessment of T-cell Epitopes as a Key Risk Factor in the Development of Anti-Therapeutic Immune Responses".